UPDATE : Wednesday, July 17, 2019
상단여백
HanAll unveils P2 trial results at ARVO 2019
HanAll Biopharma has presented the phase 2 clinical trial for HL036, a dry ...
by Lee Han-soo  |  2019-04-30 16:31
라인
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
Pharmaceutical companies are closely monitoring the supply of hepatitis A v...
by Kim Yun-mi  |  2019-04-30 13:13
라인
Daewoong gets positive reviews of its BTX in EU
Daewoong Pharmaceutical said Friday that the European Medicines Agency'...
by Lee Han-soo  |  2019-04-29 16:13
라인
Yuyu releases research results for dry eye treatment in Canada
Yuyu Pharmaceutical has presented the results of a study for YDE, its pepti...
by Lee Han-soo  |  2019-04-29 14:33
라인
Corestem fails to get insurance benefit for Lou Gehrig’s drug
A state-run health insurance review agency has refused to grant insurance b...
by Song Soo-youn  |  2019-04-26 15:43
라인
Genexine, NeoImmuneTech apply combo treatment to breast cancer
Genexine, NeoImmuneTech have started administering its combination treatmen...
by Lee Han-soo  |  2019-04-26 12:00
라인
GC wins $35.7 million flu vaccine contract from Latin America
GC said Thursday it has secured a $35.7 million contract to supply influenz...
by Lee Han-soo  |  2019-04-25 17:52
라인
Hugel submits new drug application for BTX in China
Hugel has filed a new drug application (NDA) for Botulax, its botulinum tox...
by Lee Han-soo  |  2019-04-25 16:47
라인
FDA OKs AbbVie’s plaque psoriasis treatment
The U.S. Food and Drug Administration approved Skyrizi (Ingredient: risanki...
by Lee Han-soo  |  2019-04-25 15:53
라인
Korean units of Bayer, Fresenius sent largest dividends to parent firms
Among multinational pharmaceuticals’ offshoots operating in the nation, Bay...
by Lee Han-soo  |  2019-04-25 12:02
라인
‘PD-L1 expression poor marker for bladder cancer’s immunotherapy’
More than a year has passed since Tecentriq (atezolizumab), new immunothera...
by Kim Yun-mi  |  2019-04-25 11:52
라인
Daiichi Sankyo Korea to target anticancer market
Daiichi Sankyo Korea said it would expand its business in Kora to anticance...
by Lee Han-soo  |  2019-04-24 15:43
라인
Diarrhea drug Smecta banned for children under 2
The drug authorities have banned the use of dioctahedral smectite-containin...
by Lee Hye-seon  |  2019-04-24 15:42
라인
Medytox to start P3 trials for Medytoxin in treating overactive bladder
Medytox said Wednesday that it would begin Korea’s first phase 3 clinical t...
by Lee Han-soo  |  2019-04-24 14:06
라인
[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too?
PCSK9 inhibitors have become more popular for patients with a high-risk car...
by Kim Yun-mi  |  2019-04-24 12:35
라인
Huons to market Ambio’s peptide treatment
Huons said Tuesday that it would market in Korea the generic peptide treatm...
by Lee Han-soo  |  2019-04-24 10:33
라인
Medytox launches its BTX in Mexico
Medytox said Monday that it has launched Acebloc, the company’s botulinum t...
by Lee Han-soo  |  2019-04-23 17:30
라인
Takeda’s lung cancer drug to get insurance benefit
Takeda’s Alunbrig (ingredient: Brigatinib), an anaplastic lymphoma kinase (...
by Lee Han-soo  |  2019-04-23 11:48
라인
Harvard professor to join OliX Pharmaceuticals’ scientific advisory board
OliX Pharmaceuticals said Monday that Professor Demetrios G. Vavvas, one of...
by Lee Han-soo  |  2019-04-23 11:47
라인
‘Darzalex as another weapon against multiple myeloma’
Janssen Korea’s Darzalex (ingredient: daratumumab) is effective for heavily...
by Park Gi-taek  |  2019-04-19 15:39
-12345678910-
‘RIGHT Fund aims to use Korean innovation for global health equality’‘RIGHT Fund aims to use Korean innovation for global health equality’
여백
Most viewed
여백
Opinion
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
여백
Back to Top